Herceptin improves stomach cancer survival: study
Wednesday 10 June 2009
Herceptin, the breast cancer drug developed by Genentech, reduces the risk of death for certain stomach cancer patients by 26 percent compared with chemotherapy alone, according to new research.
>> http://www.reuters.com/article/healthNews/idUSTRE54U1FY20090531
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu